Atherosclerotic cerebro-cardiovascular disease is multi-vascular and multi-organ disease resulting from both chronic and acute risk factors. BP, blood pressure; ACS, acute coronary syndrome, CCS, chronic coronary syndrome; HFrEF, heart failure with reduced ejection fraction; HFpEF heart failure with preserved ejection fraction, PAD peripheral artery disease, CKD chronic kidney disease, RF renal failure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41440-024-01966-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lipid-related radiomics of low-echo carotid plaques is associated with diabetic stroke and non-diabetic coronary heart disease.
Int J Cardiovasc Imaging
January 2025
Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, No. 107, West Yanjiang Road, Guangzhou, 510120, China.
Carotid plaque radiomics-included models have increased the predictive capacity of cardiovascular risk, but the radiomic features of these models were inconsistent in previous studies. Lipids could be used to select the most important radiomic feature. A retrospective case‒control study was performed in 153 diabetic and 76 non-diabetic patients with carotid plaque detected by ultrasound.
View Article and Find Full Text PDFPrevention of atherosclerotic cerebro-cardiovascular disease: a key objective in blood pressure management for coronary artery disease in East Asia.
Hypertens Res
October 2024
Department of Cardiology, Kurume University Medical Center, Kurume, Fukuoka, 839-0863, Japan.
Atherosclerotic cerebro-cardiovascular disease is multi-vascular and multi-organ disease resulting from both chronic and acute risk factors. BP, blood pressure; ACS, acute coronary syndrome, CCS, chronic coronary syndrome; HFrEF, heart failure with reduced ejection fraction; HFpEF heart failure with preserved ejection fraction, PAD peripheral artery disease, CKD chronic kidney disease, RF renal failure.
View Article and Find Full Text PDFA Radiomics-Based Nomogram Using Ultrasound Carotid Plaque Evaluation For Predicting Cerebro-Cardiovascular Events In Asymptomatic Patients.
Acad Radiol
December 2024
Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Dadao, Wuhan 430030, China. Electronic address:
Rationale And Objectives: This study aims to assess whether a radiomics-based nomogram correlates with a higher risk of future cerebro-cardiovascular events in patients with asymptomatic carotid plaques. Additionally, it investigates the nomogram's contribution to the revised Framingham Stroke Risk Profile (rFSRP) for predicting cerebro-cardiovascular risk.
Materials And Methods: Predictive models aimed at identifying an increased risk of future cerebro-cardiovascular events were developed and internally validated at one center, then externally validated at two other centers.
Biofilms exacerbate atherogenesis through macrophage-induced inflammatory responses in a fibrous plaque microsystem model.
Acta Biomater
September 2023
Department of Biomedical Engineering, City University of Hong Kong; Hong Kong Center for Cerebro-Cardiovascular Health Engineering (COCHE); City University of Hong Kong - Futian Shenzhen Research Institute. Electronic address:
Background: Microbes have been implicated in atherosclerosis development and progression, but the impact of bacterial-based biofilms on fibrous plaque rupture remains poorly understood.
Results: Here, we developed a comprehensive atherosclerotic model to reflect the progression of fibrous plaque under biofilm-induced inflammation (FP-I). High expressions of biofilm-specific biomarkers algD, pelA and pslB validated the presence of biofilms.
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP).
Prog Cardiovasc Dis
November 2023
Cardiology Department, University Hospital La Paz, Madrid, Spain.
Cardiovascular disease (CVD) is a chronic non-communicable disease (NCD) and the predominant cause of morbidity and mortality worldwide. Substantial reductions in the CVD prevalence have been achieved in recent years by the attenuation of risk factors (particularly hypertension and dyslipidaemias) in primary and secondary prevention. Despite the remarkable success of lipid lowering treatments, and of statins in particular, in reducing the risk of CVD, there is still an unmet clinical need for the attainment of guideline lipid-targets in even 2/3 of patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!